428
Views
12
CrossRef citations to date
0
Altmetric
Review

Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment

, &
Pages 675-684 | Received 28 Jun 2020, Accepted 06 Jul 2021, Published online: 26 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bing-Qing Li, Jie Ding, Chang-Guang Zeng, Yu-Yang Song, Kai Xia, Yi Ai, Jun-Jie Zhu, Hang Zhong & Zhi-Xu Zhou. (2023) Synthesis, X-ray crystal structure, DFT calculation and anti-tumor research of novel-configurational dihydroartemisinin purine hybrids. Molecular Crystals and Liquid Crystals 756:1, pages 58-73.
Read now
Jader Pires, Suéllen Alves Costa, Karoline Paiva da Silva, Aline Gomes Batista da Conceição, Érica de Melo Reis, Adilson Paulo Sinhorin, Carmen Lucia Bassi Branco, Letícia Cruz, Stela Regina Ferrarini & Cláudia Marlise Balbinotti Andrade. (2022) Artemether-loaded polymeric lipid-core nanocapsules reduce cell viability and alter the antioxidant status of U-87 MG cells. Pharmaceutical Development and Technology 27:8, pages 892-903.
Read now

Articles from other publishers (10)

Ninglin Zhao, Yingjie Song, Xiangqian Xie, Ziqi Zhu, Chenxi Duan, Cheng Nong, Huan Wang & Rui Bao. (2023) Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. Signal Transduction and Targeted Therapy 8:1.
Crossref
Xiaohua Lu, Mohamed Elbadawi, Sebastian Blatt, Mohamed E.M. Saeed, Xiaolin Xiao, Xiao Ma, Edmond Fleischer, Peer W. Kämmerer & Thomas Efferth. (2022) Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion. Chemico-Biological Interactions 365, pages 110062.
Crossref
Essa M. Bajalia, Farah B. Azzouz, Danielle A. Chism, Derrek M. Giansiracusa, Carina G. Wong, Kristina N. Plaskett & Anupam Bishayee. (2022) Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms. Cancers 14:13, pages 3278.
Crossref
Elʹvin Gadzhi ogly Kerimli, Adilya Novruz kyzy Aleskerova & Siradzheddin Veli ogly Serkerov. (2022) SESQUITERPENE LACTONS FROM AERIAL PARTS OF ARTEMISIA CAMPESTRIS (var. MARSCHALLIANA) SPRENG.. chemistry of plant raw material:2, pages 129-135.
Crossref
Saleha Anwar, Debarati DasGupta, Naved Azum, Sulaiman Y.M. Alfaifi, Abdullah M. Asiri, Fahad A. Alhumaydhi, Suliman A. Alsagaby, Sharaf E. Sharaf, Moyad Shahwan & Md. Imtaiyaz Hassan. (2022) Inhibition of PDK3 by artemisinin, a repurposed antimalarial drug in cancer therapy. Journal of Molecular Liquids 355, pages 118928.
Crossref
Rajeev K. Singla, Sahar Behzad, Johra Khan, Christos Tsagkaris, Rupesh K. Gautam, Rajat Goyal, Hitesh Chopra & Bairong Shen. (2022) Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies. Frontiers in Pharmacology 13.
Crossref
Xinyu Zhou, Fengzhi Suo, Kristina Haslinger & Wim J. Quax. (2022) Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery. Pharmaceutics 14:2, pages 395.
Crossref
Haodong Hou, Bin Qu, Chen Su, Guihua Hou & Feng Gao. (2021) Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids. Frontiers in Pharmacology 12.
Crossref
Wamidh H. Talib, Ahmad Riyad Alsayed, Muna Barakat, May Ibrahim Abu-Taha & Asma Ismail Mahmod. (2021) Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines 9:10, pages 1353.
Crossref
Hao Zhang, Renzheng Liu, Lin Sun, Weidong Guo & Xiao Hu. (2021) The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma. Journal of Oncology 2021, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.